{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Steroid 16-alpha-hydroxylase : Questions médicales les plus fréquentes",
"headline": "Steroid 16-alpha-hydroxylase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Steroid 16-alpha-hydroxylase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Steroid 16-alpha-hydroxylase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Steroid hydroxylases",
"url": "https://questionsmedicales.fr/mesh/D013250",
"about": {
"@type": "MedicalCondition",
"name": "Steroid hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D013250",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.915"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Steroid 16-alpha-hydroxylase",
"alternateName": "Steroid 16-alpha-Hydroxylase",
"code": {
"@type": "MedicalCode",
"code": "D039181",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ki-Hwa Kim",
"url": "https://questionsmedicales.fr/author/Ki-Hwa%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Tae-Jin Oh",
"url": "https://questionsmedicales.fr/author/Tae-Jin%20Oh",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Chang Woo Lee",
"url": "https://questionsmedicales.fr/author/Chang%20Woo%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Research Unit of Cryogenic Novel Materials, Korea Polar Research Institute, Incheon 21990, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Pradeep Subedi",
"url": "https://questionsmedicales.fr/author/Pradeep%20Subedi",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36718727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737140.2023.2171991"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37534902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aja20239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03848-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staging Prostate Cancer with",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37116912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnumed.122.265371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate MRI Qualification:",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35544372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2214/AJR.22.27615"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytochromes",
"item": "https://questionsmedicales.fr/mesh/D003580"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cytochrome P-450 enzyme system",
"item": "https://questionsmedicales.fr/mesh/D003577"
},
{
"@type": "ListItem",
"position": 7,
"name": "Steroid hydroxylases",
"item": "https://questionsmedicales.fr/mesh/D013250"
},
{
"@type": "ListItem",
"position": 8,
"name": "Steroid 16-alpha-hydroxylase",
"item": "https://questionsmedicales.fr/mesh/D039181"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Steroid 16-alpha-hydroxylase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Steroid 16-alpha-hydroxylase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Steroid 16-alpha-hydroxylase",
"description": "Comment diagnostiquer une déficience en 16-alpha-hydroxylase ?\nQuels tests génétiques sont utilisés pour cette enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nQuel rôle joue l'imagerie dans le diagnostic ?\nLes tests de fonction hépatique sont-ils pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Prostatic+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Steroid 16-alpha-hydroxylase",
"description": "Quels sont les symptômes d'une surproduction d'androgènes ?\nComment se manifeste une insuffisance en stéroïdes ?\nLes symptômes varient-ils selon le sexe ?\nY a-t-il des symptômes associés à des troubles métaboliques ?\nLes symptômes peuvent-ils apparaître à l'adolescence ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Prostatic+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Steroid 16-alpha-hydroxylase",
"description": "Peut-on prévenir les troubles liés à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nComment l'éducation peut-elle aider à la prévention ?\nLes habitudes alimentaires influencent-elles la santé hormonale ?\nLe stress a-t-il un impact sur cette enzyme ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Prostatic+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Steroid 16-alpha-hydroxylase",
"description": "Quels traitements sont disponibles pour les déséquilibres hormonaux ?\nLes médicaments peuvent-ils aider à réguler cette enzyme ?\nY a-t-il des traitements non médicamenteux ?\nComment la chirurgie peut-elle être impliquée ?\nLes traitements sont-ils différents pour les hommes et les femmes ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Prostatic+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Steroid 16-alpha-hydroxylase",
"description": "Quelles complications peuvent survenir avec un déséquilibre hormonal ?\nLes troubles psychologiques sont-ils liés à cette enzyme ?\nY a-t-il des risques de cancer associés ?\nComment les maladies métaboliques sont-elles liées ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Prostatic+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Steroid 16-alpha-hydroxylase",
"description": "Quels facteurs de risque sont associés à des troubles hormonaux ?\nL'âge influence-t-il le risque de déséquilibre hormonal ?\nLes médicaments peuvent-ils affecter cette enzyme ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Prostatic+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en 16-alpha-hydroxylase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour mesurer les niveaux d'hormones stéroïdiennes sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés pour cette enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses génétiques ciblent les mutations dans le gène CYP3A4."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'hyperandrogénie ou des irrégularités menstruelles peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les glandes endocrines, mais n'est pas spécifique."
}
},
{
"@type": "Question",
"name": "Les tests de fonction hépatique sont-ils pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, car le foie est crucial pour le métabolisme des stéroïdes et peut indiquer des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surproduction d'androgènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Acné, hirsutisme, irrégularités menstruelles et infertilité peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une insuffisance en stéroïdes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de poids, hypotension et dépression peuvent être des signes d'insuffisance."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le sexe ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes et les femmes peuvent présenter des symptômes différents en raison des hormones."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à des troubles métaboliques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme le diabète peuvent être liés à des anomalies hormonales."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître à l'adolescence ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements hormonaux peuvent se manifester durant la puberté."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés à cette enzyme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et un mode de vie sain peuvent aider à prévenir certains troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests hormonaux réguliers peuvent être recommandés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "Comment l'éducation peut-elle aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les symptômes et les risques peut aider à une détection précoce."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé hormonale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir la santé hormonale et prévenir des déséquilibres."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur cette enzyme ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la production hormonale et aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déséquilibres hormonaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies hormonales substitutives peuvent être prescrites pour rétablir l'équilibre."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler cette enzyme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains inhibiteurs enzymatiques peuvent être utilisés pour moduler l'activité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme l'alimentation et l'exercice, peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment la chirurgie peut-elle être impliquée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, une intervention chirurgicale peut être nécessaire pour corriger des anomalies."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les hommes et les femmes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins hormonaux spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un déséquilibre hormonal ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'infertilité, le diabète et des maladies cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils liés à cette enzyme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme l'anxiété et la dépression peuvent être exacerbés par des déséquilibres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les déséquilibres hormonaux et le cancer hormonal."
}
},
{
"@type": "Question",
"name": "Comment les maladies métaboliques sont-elles liées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déséquilibres hormonaux peuvent contribuer à des maladies métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et précoce."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à des troubles hormonaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux, l'obésité et le stress sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de déséquilibre hormonal ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout pendant la ménopause chez les femmes."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils affecter cette enzyme ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec l'activité de la stéroïde 16-alpha-hydroxylase."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut affecter la fonction hormonale."
}
}
]
}
]
}
The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence ...
We searched the literature via PubMed, MEDLINE, and Embase for studies from 2014 to the present addressing focal therapy with non-palliative intent in metastatic prostate cancer patients, emphasizing ...
Current evidence is strongest, and in our opinion practice-changing, for prostate-directed RT in de novo metastatic patients with low metastatic burden. Metastasis-directed therapy with SBRT is consis...
Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) a...
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usu...
Although prostate-specific membrane antigen (PSMA) PET/CT has been shown valuable for staging biopsy-proven [B(+)] high-risk prostate cancer, elderly patients are occasionally referred for PSMA PET/CT...
Prostate MRI is now established as a first-line investigation for individuals presenting with suspected localized or locally advanced prostate cancer. Successful delivery of the MRI-directed pathway f...
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer p...
There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We have previously repo...
To further develop and adapt the MiCheck® Prostate test so it can be performed using a standard clinical chemistry analyzer and characterize its performance using the MiCheck-01 clinical trial sample ...
About 358 patient samples from the MiCheck-01 US clinical trial were used for the development of the MiCheck® Prostate test. These consisted of 46 controls, 137 non-CaP, 62 non-CSCaP, and 113 CSCaP....
Serum analyte concentrations for cellular growth factors were determined using custom-made Luminex-based R&D Systems multi-analyte kits. Analytes that can also be measured using standard chemistry ana...
Logistic regression modeling with Monte Carlo cross-validation was used to identify Human Epidydimal Protein 4 (HE4) as an analyte able to significantly improve the algorithm specificity at 95% sensit...
The MiCheck® logistic regression model was developed and consisted of PSA, %free PSA, DRE, and HE4. The model differentiated clinically significant cancer from no cancer or not-clinically significant ...
The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas...
Prostate health index (PHI) and, more recently, Proclarix have been proposed as serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix and PHI for predicting clinica...
Proclarix and PHI were measured using samples of 344 men from two different centers. All patients underwent prostate biopsy, and among those, 188 men with PCa on biopsy had an additional radical prost...
The cohort median age and PSA were 65 (interquartile range [IQR]: 60-71) and 5.6 (IQR: 4.3-7.2) ng/ml, respectively. CsPCa was diagnosed in 161 (47%) men based on the RP specimen. ROC analysis showed ...
Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic perfor...
Transperineal (TP) multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has been shown to detect more clinically significant (cs) prostate cancer (PCa) than standard template biops...
We identified all men who with suspicious lesions on mpMRI and underwent TP TBx (3-core) and concomitant SBx (20-core) in our single hospital from September 2019 to February 2021. Clinical, MRI and bi...
Three hundred and one (n = 301) men were included. The median prostate volume by MRI was 45 ml. The patients were divided by prostate volume into three groups: ≤30ml group (19.9%), >30 to ≤45 ml group...
Our data suggest that performing TBx with limited additional cores may potentially achieve the same csPCa detection rate as the combined SBx and TBx in smaller prostates....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...